Orion Portfolio Solutions’s Bio-Rad Laboratories Class A BIO Stock Holding History

Orion Portfolio Solutions’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$831K	Buy	3,410 +146	+4%	+$43.9K	0.01%	1178
2024 Q4	$1.07M	Sell	3,264 -219	-6%	-$74.3K	0.01%	1013
2024 Q3	$1.17M	Sell	3,483 -201	-5%	-$63.8K	0.01%	964
2024 Q2	$1.01M	Sell	3,684 -367	-9%	-$107K	0.01%	988
2024 Q1	$1.4M	Sell	4,051 -2,048	-34%	-$673K	0.02%	833
2023 Q4	$1.96M	Sell	6,099 -2,012	-25%	-$631K	0.02%	642
2023 Q3	$2.91M	Sell	8,111 -340	-4%	-$131K	0.04%	457
2023 Q2	$3.2M	Buy	8,451 +604	+8%	+$246K	0.03%	457
2023 Q1	$3.76M	Buy	+7,847	New	+$3.67M	0.05%	341
2020 Q3	–	Sell	-9	Closed	-$4K	–	606
2020 Q2	$4K	Buy	9 +6	+200%	+$2.65K	﹤0.01%	1524
2020 Q1	$1K	Sell	3 -1	-25%	-$368	﹤0.01%	1680
2019 Q4	$1K	Buy	+4	New	+$1.41K	﹤0.01%	1610

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Orion Portfolio Solutions's BIO Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Bio-Rad Laboratories Class A (BIO) stake by 4.5% in Q1 2025, buying an estimated $43.9K and bringing the position to 3,410 shares worth $831K. The position accounts for 0.01% of the portfolio, ranked #1178.

Orion Portfolio Solutions first reported a position in BIO in Q4 2019 and has held it in 12 quarters since. The position peaked at $3.76M in Q1 2023. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

Orion Portfolio Solutions held 3,410 shares of Bio-Rad Laboratories Class A worth $831K as of Q1 2025.
Orion Portfolio Solutions bought 146 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $43.9K.
Bio-Rad Laboratories Class A made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1178 holding.
Orion Portfolio Solutions first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and has held it in 12 quarters since.
Orion Portfolio Solutions's Bio-Rad Laboratories Class A position peaked at $3.76M in Q1 2023.
436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.